✦ LIBER ✦

Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial

✍ Scribed by Akhondzadeh, Shahin; Mohammadi, Neyousha; Noroozian, Maryam; Karamghadiri, Naregs; Ghoreishi, Aboulfazl; Jamshidi, Amir-Hossein; Forghani, Saeedeh

Book ID: 123401303
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 397 KB
Volume: 107
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2008.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Added donepezil for stable schizophrenia

Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial

✍ Oliver Freudenreich; Lawrence Herz; Thilo Deckersbach; A. Eden Evins; David C. H 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 107 KB

Ondansetron. A double blind placebo cont

Ondansetron. A double blind placebo controlled study in acute schizophrenia

✍ McBain, S.L.; Dineen, M.; Weller, M.; Taylor, S.; Cooksey, P.; Williams, P.; Cor 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 106 KB

A double-blind, placebo-controlled trial

✍ Robert S. Pinals; Stanley B. Kaplan; Jeffrey G. Lawson; Bonnie Hepburn 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

65-139 - A double-blind, placebo-control

65-139 - A double-blind, placebo-controlled trial of sertraline for depressive symptoms in stable, chronic schizophrenia

✍ C. Mulholland; G. Lynch; S.J. Cooper; D.J. King 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Nifedipine in chronic stable angina: A d

Nifedipine in chronic stable angina: A double-blind placebo-controlled crossover trial

✍ Lon G. Sherman; Chang-Seng Liang 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 680 KB

Tolcapone added to levodopa in stable pa

Tolcapone added to levodopa in stable parkinsonian patients: A double-blind placebo-controlled study

✍ Dr. Erik Dupont; Jean-Marc Burgunder; Leslie J. Findley; Jan-Edvin Olsson; Ernes 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

The primary objective of this study was to assess the effect of tolcapone on levodopa dosage in parkinsonian patients whose "wearing-off" phenomenon has been controlled with more frequent levodopa dosage. After a 1-week placebo run-in, 97 patients were assigned randomly to receive placebo or tolcapo